149 related articles for article (PubMed ID: 33244199)
41. Evaluation of miR-122 Serum Level and IFN-λ3 Genotypes in Patients with Chronic HCV and HCV-Infected Liver Transplant Candidate.
Moayedi J; Hashempour T; Musavi Z; Arefian E; Naderi M; Heidari MR; Dehghani B; Hasanshahi Z; Merat S
Microrna; 2021; 10(1):58-65. PubMed ID: 33334303
[TBL] [Abstract][Full Text] [Related]
42. Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma.
Mohamed AA; Loutfy SA; Craik JD; Hashem AG; Siam I
Virol J; 2011 Nov; 8():496. PubMed ID: 22044490
[TBL] [Abstract][Full Text] [Related]
43. Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infection.
Kitson MT; George J; Dore GJ; Leung R; Button P; McCaughan GW; Grawford DH; Siebert W; Weltman MD; Cheng WS; Roberts SK
J Gastroenterol Hepatol; 2014; 29(7):1458-62. PubMed ID: 25587616
[TBL] [Abstract][Full Text] [Related]
44. Role of
Barooah P; Saikia S; Bharadwaj R; Sarmah P; Bhattacharyya M; Goswami B; Medhi S
Genet Test Mol Biomarkers; 2019 May; 23(5):325-331. PubMed ID: 30942619
[No Abstract] [Full Text] [Related]
45. TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype.
Sagnelli C; Merli M; Uberti-Foppa C; Hasson H; Grandone A; Cirillo G; Salpietro S; Minichini C; Starace M; Messina E; Morelli P; Miraglia Del Giudice E; Lazzarin A; Coppola N; Sagnelli E
World J Gastroenterol; 2016 Oct; 22(38):8509-8518. PubMed ID: 27784963
[TBL] [Abstract][Full Text] [Related]
46. Genetic Variants in the Promoter Region of the Macrophage Migration Inhibitory Factor are Associated with the Severity of Hepatitis C Virus-Induced Liver Fibrosis.
Wirtz TH; Fischer P; Backhaus C; Bergmann I; Brandt EF; Heinrichs D; Koenen MT; Schneider KM; Eggermann T; Kurth I; Stoppe C; Bernhagen J; Bruns T; Fischer J; Berg T; Trautwein C; Berres ML
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370326
[TBL] [Abstract][Full Text] [Related]
47. Impact of
Jiménez-Sousa MÁ; Gómez-Moreno AZ; Pineda-Tenor D; Sánchez-Ruano JJ; Artaza-Varasa T; Martin-Vicente M; Fernández-Rodríguez A; Martínez I; Resino S
Biomolecules; 2019 Apr; 9(4):. PubMed ID: 30970632
[No Abstract] [Full Text] [Related]
48. IL28B polymorphism and cytomegalovirus predict response to treatment in Egyptian HCV type 4 patients.
El Awady MK; Bader El Din NG; Tabll A; El Hosary Y; Abdel Aziz AO; El Khayat H; Salama M; Abdelhafez TH
World J Gastroenterol; 2013 Jan; 19(2):290-8. PubMed ID: 23345953
[TBL] [Abstract][Full Text] [Related]
49. The Impact of Interferon-γ (IFN-γ) and IFN-γ-Inducible Protein 10 (IP-10) Genes' Polymorphism on Risk of Hepatitis C Virus-Related Liver Cirrhosis.
Talaat RM; Elsharnoby S; Abdelkhalek MS; El-Shenawy SZ; Elmasry S
Immunol Invest; 2022 Apr; 51(3):688-704. PubMed ID: 33445993
[TBL] [Abstract][Full Text] [Related]
50. Role of PNPLA3 in the Assessment and Monitoring of Hepatic Steatosis and Fibrosis in Patients with Chronic Hepatitis C Infection Who Achieved a Sustained Virologic Response.
Gavril OI; Arhire LI; Gavrilescu O; Dranga M; Barboi O; Gavril RS; Popescu R; Cijevschi Prelipcean C; Trifan AV; Mihai C
Medicina (Kaunas); 2021 Oct; 57(11):. PubMed ID: 34833371
[No Abstract] [Full Text] [Related]
51. Interferon-γ and Interleukin-10 Gene Polymorphisms are not Predictors of Chronic Hepatitis C (Genotype-4) Disease Progression.
Bahgat NA; Kamal MM; Abdelaziz AO; Mohye MA; Shousha HI; ahmed MM; Elbaz TM; Nabil MM
Asian Pac J Cancer Prev; 2015; 16(12):5025-30. PubMed ID: 26163635
[TBL] [Abstract][Full Text] [Related]
52. The TGFB1 -509C/T polymorphism and elevated TGF-β1 levels are associated with chronic hepatitis C and cirrhosis.
de Brito WB; Queiroz MAF; da Silva Graça Amoras E; Lima SS; da Silva Conde SRS; Dos Santos EJM; Cayres-Vallinoto IMV; Ishak R; Vallinoto ACR
Immunobiology; 2020 Sep; 225(5):152002. PubMed ID: 32962821
[TBL] [Abstract][Full Text] [Related]
53. Peripheral blood and hepatic Toll-like receptor 7 expression and interferon lambda 1 levels in chronic hepatitis C: Relation to virus replication and liver injury.
El Aggan H; Farahat N; El Deeb N; Zeid A; El-Shendidi A
Microb Pathog; 2019 Jun; 131():65-74. PubMed ID: 30926417
[TBL] [Abstract][Full Text] [Related]
54. Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.
Giannini E; Ceppa P; Botta F; Mastracci L; Romagnoli P; Comino I; Pasini A; Risso D; Lantieri PB; Icardi G; Barreca T; Testa R
Am J Gastroenterol; 2000 Nov; 95(11):3211-7. PubMed ID: 11095344
[TBL] [Abstract][Full Text] [Related]
55. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
[TBL] [Abstract][Full Text] [Related]
56. Variations in DEPDC5 gene and its association with chronic hepatitis C virus infection in Saudi Arabia.
Al-Anazi MR; Matou-Nasri S; Abdo AA; Sanai FM; Khan MQ; Albenmousa A; Al-Ashgar HI; Khalaf NZ; Al-Ahdal MN; Al-Qahtani AA
BMC Infect Dis; 2014 Dec; 14():632. PubMed ID: 25551790
[TBL] [Abstract][Full Text] [Related]
57. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
[TBL] [Abstract][Full Text] [Related]
58. High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C.
Hsu CS; Liu CJ; Liu CH; Wang CC; Chen CL; Lai MY; Chen PJ; Kao JH; Chen DS
Liver Int; 2008 Feb; 28(2):271-7. PubMed ID: 18028320
[TBL] [Abstract][Full Text] [Related]
59. Clinical implications of alpha-fetoprotein in chronic hepatitis C.
Tai WC; Hu TH; Wang JH; Hung CH; Lu SN; Changchien CS; Lee CM
J Formos Med Assoc; 2009 Mar; 108(3):210-8. PubMed ID: 19293036
[TBL] [Abstract][Full Text] [Related]
60. IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes.
Bochud PY; Bibert S; Kutalik Z; Patin E; Guergnon J; Nalpas B; Goossens N; Kuske L; Müllhaupt B; Gerlach T; Heim MH; Moradpour D; Cerny A; Malinverni R; Regenass S; Dollenmaier G; Hirsch H; Martinetti G; Gorgiewski M; Bourlière M; Poynard T; Theodorou I; Abel L; Pol S; Dufour JF; Negro F; ;
Hepatology; 2012 Feb; 55(2):384-94. PubMed ID: 22180014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
